Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Are there still indications for plasma transfusions?]

P C Huijgens, G J Ossenkoppele, R N Pietersz

    Nederlands Tijdschrift Voor Geneeskunde
    |December 14, 1991
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

    Leukemia·2024
    Same author

    Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

    Leukemia·2022
    Same author

    The war on clones: a Darwinian enigma.

    Blood·2021
    Same author

    Evaluating ivosidenib for the treatment of acute myeloid leukemia.

    Expert opinion on pharmacotherapy·2020
    Same author

    Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

    Leukemia·2020
    Same author

    Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

    Leukemia·2020